About: Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 14 September 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2006 (fr) наукова стаття, опублікована у вересні 2006 (uk) im September 2006 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 14 September 2006 (en) artículu científicu espublizáu en setiembre de 2006 (ast)
publication date	wds:Q79162330-024ABB48-3786-4F47-8C3A-7E895FCB3267
publication date	2006-09-14 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q79162330-3FBA315B-C2FF-4D42-91A7-1B2972530FE9
language of work or name	English
author name string	wds:Q79162330-0770AFDE-EE00-434B-BC40-C1409A079AC6 wds:Q79162330-2E6379C0-6775-48DF-8EF7-356047EF0A03 wds:Q79162330-31539398-5829-434A-9D57-CC9ABF0C3B8B wds:Q79162330-4AC8A590-3837-45D9-8033-CD139FEB73D3 wds:Q79162330-53BAA406-04CB-4894-A200-9CA2C0A6DB50 wds:Q79162330-58A52661-BF3B-4CA0-93AB-D7D6F6F2C712 wds:Q79162330-5D0306BB-DBF6-4374-A0D2-EF20B0824B9A wds:Q79162330-93621FC0-EC70-4C0E-8E4F-B73A9614A379 wds:Q79162330-B74C9C4C-8AEE-43C9-8A40-7033426EA2FA wds:Q79162330-BA5C3E8D-A62A-4C12-8C9D-E3BC671F4106 wds:Q79162330-C1C9DAEC-5FB1-4728-A0E0-94304F470B36 wds:Q79162330-CA21A8FB-7B3B-4C99-8CAB-4C4440F27205 wds:Q79162330-DB001935-FAB0-4EF1-AF96-A952ED3B0F6F
author name string	Hui Li Ping Chen Jing Jin Robert M Graham Xinyan Li Zhaoming Li Donna Lai Xifu Liu Mingdong Zhou Xinhua Gu Bing Xi Denghong Chen Jianjie Chang
rdfs:label	Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy (en) Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy (nl)
skos:prefLabel	Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy (en) Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy (nl)
name	Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy (en) Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy (nl)
title	wds:Q79162330-2B823E6B-ED0E-4902-A4C9-2F347B9DC5B5
title	Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy (en)
page(s)	wds:Q79162330-B6B84410-1A63-4A3A-84D9-A841CA254319
page(s)	1438-1447
instance of	wds:Q79162330-6C57500B-2042-4B63-BD95-E8D2E38EB223
instance of	scholarly article
main subject	wds:Q79162330-DEFF5E76-BC45-475B-B59C-E13077CFCCBD
main subject	Viral cardiomyopathy
PubMed ID	wds:Q79162330-7D043463-0632-4752-8764-65C8FC57197D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17010808
PubMed ID	17010808
published in	wds:Q79162330-CFB4FE5B-48EF-404B-8BC5-3A8F21BECED8
published in	Journal of the American College of Cardiology
issue	wds:Q79162330-F682A0FE-4707-4C37-8318-B4881F1B45FB
volume	wds:Q79162330-45AD453F-7699-4305-9E2B-E2D631959979
issue	7
volume	48
DOI	wds:Q79162330-14541CA2-F4E6-400D-ABD8-AE4921C02A6C
DOI	http://dx.doi.org/10.1016/J.JACC.2006.05.057
DOI	10.1016/J.JACC.2006.05.057
Fatcat ID	wds:Q79162330-EE654671-846A-423D-8A47-9A908ED6CF03
Fatcat ID	release_3nmcfadeqbhy7f66rhamdsdepu
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q79162330
is cites work of	Anthracycline cardiotoxicity: from bench to bedside Protein engineering for cardiovascular therapeutics: untapped potential for cardiac repair A dual role for ErbB2 signaling in cardiac trabeculation ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium The role of Neuregulin-1beta/ErbB signaling in the heart Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure. The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics. ErbB2 signaling at the crossing between heart failure and cancer Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy. Recombinant neuregulin 1 does not activate cardiomyocyte DNA synthesis in normal or infarcted adult mice. Anti-remodeling and anti-fibrotic effects of the neuregulin-1β glial growth factor 2 in a large animal model of heart failure The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation The roles of neuregulin-1 in cardiac development, homeostasis, and disease ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation. ErbB signaling in cardiac development and disease Cardiac muscle regeneration: lessons from development The effects of neuregulin on cardiac Myosin light chain kinase gene-ablated hearts Chronic pharmacologic inhibition of EGFR leads to cardiac dysfunction in C57BL/6J mice Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery Novel biomarkers in chronic heart failure Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways Molecular regulation of cardiomyocyte differentiation An engineered bivalent neuregulin protects against doxorubicin-induced cardiotoxicity with reduced proneoplastic potential. Serum Neuregulin-1beta as a Biomarker of Cardiovascular Fitness. Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure. Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarction Neuregulin-1β for the treatment of systolic heart failure Cytostatic drugs, neuregulin activation of erbB receptors, and angiogenesis Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology Neuregulin-1/ErbB signaling and chronic heart failure Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver. Systems biology approaches to adverse drug effects: the example of cardio-oncology Hypoxia changes the expression of the epidermal growth factor (EGF) system in human hearts and cultured cardiomyocytes.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software